CD36 and melanoma: For this, we tracked PC uptake in melanoma cells treated with a CD36 inhibitor (salvianolic acid B, CD36i), which confirmed that inhibition of CD36 abrogates Cy5-PC uptake (Figures 5G and S5G), melanoma proliferation and ROS production (Figures S5A–S5F).